Maynard Um
-
-
-
-
-
-
-
Kenvue Inc (KVUE) PT Raised to $19 at UBS
-
-
-
-
-
-
-
Kimberly-Clark and Kenvue shareholders approve acquisition deal
-
-
-
-
-
-
-
Activist Investor D.E. Shaw Expected to Break Even on Kenvue After Kimberly-Clark Deal - WSJ
-
-
-
-
-
-
-
HHS Secretary Kennedy on Tylenol: not enough evidence to show Tylenol definitively causes autism but some studies seem 'very suggestive'
-
-
-
-
-
-
-
UBS Reiterates Neutral Rating on Kenvue Inc (KVUE) as Shares Down on Report of UK Class Action Suit
-
-
-
-
-
-
-
Rothschild Redburn Upgrades Kenvue Inc (KVUE) to Buy
-
-
-
-
-
-
-
Kenvue stock falls after report of Trump admin linking Tylenol to autism
-
404,866 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

